Evidence
J Clin Invest. 2024 Mar 1;134(5):e175036. doi: 10.1172/JCI175036.
ABSTRACT
Fragile X syndrome (FXS), the most common inherited cause of intellectual disability and the single-gene cause of autism, is caused by decreased expression of the fragile X messenger ribonucleoprotein protein (FMRP), a ribosomal-associated RNA-binding protein involved in translational repression. Extensive preclinical work in several FXS animal models supported the therapeutic potential of decreasing metabotropic glutamate receptor (mGluR) signaling to correct translation of proteins related to synaptic plasticity; however, multiple clinical trials failed to show conclusive evidence of efficacy. In this issue of the JCI, Berry-Kravis and colleagues conducted the FXLEARN clinical trial to address experimental design concerns from previous trials. Unfortunately, despite treatment of young children with combined pharmacological and learning interventions for a prolonged period, no efficacy of blocking mGluR activity was observed. Future systematic evaluation of potential therapeutic approaches should evaluate consistency between human and animal pathophysiological mechanisms, utilize innovative clinical trial design from FXLEARN, and incorporate translatable biomarkers.
PMID:38426491 | DOI:10.1172/JCI175036
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research
🌐 90 Days
VR Related Evidence Matrix
- Role of Fragile X Messenger Ribonucleoprotein 1 in the pathophysiology of brain disorders: a glia perspective
- Loss of FMRP affects ovarian development and behaviour through multiple pathways in a zebrafish model of fragile X syndrome
- Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology
- Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients
- PGC-1α integrates insulin signaling with mitochondrial physiology and behavior in a Drosophila model of Fragile X Syndrome
- Topography and ensemble activity in auditory cortex of a mouse model of Fragile-X-Syndrome
- Assessment of dental and periodontal indices and Streptococcus mutans virulence in fragile X syndrome patients
- Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome
- Assessment of the excitation-inhibition ratio in the Fmr1 KO2 mouse using neuronal oscillation dynamics
- Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: obligatory role of hippocampal GPR55 receptors
- ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel-Van der Aa syndrome autopsy case
- SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity
- Serotonin Signaling through Lipid Membranes
- SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD
- Autistic Traits Associated with the Fragile X Premutation Allele: The Neurodevelopmental Profile
- Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research
- Selective vulnerability of the ventral hippocampus-prelimbic cortex axis parvalbumin interneuron network underlies learning deficits of fragile X mice
- Comprehensive translational profiling and STE AI uncover rapid control of protein biosynthesis during cell stress
- Ligand-gated ion channels as potential biomarkers for ADT-mediated cognitive decline in prostate cancer patients
- The impact of IDR phosphorylation on the RNA binding profiles of proteins
- The impact of IDR phosphorylation on the RNA binding profiles of proteins
- Ribosomal quality control factors inhibit repeat-associated non-AUG translation from GC-rich repeats
- Distinct SAP102 and PSD-95 nano-organization defines multiple types of synaptic scaffold protein domains at single synapses
- Altered lipid homeostasis is associated with cerebellar neurodegeneration in SNX14 deficiency
- Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
- Neuropsychiatric Aspects of Sotos Syndrome: Explorative Review Building Multidisciplinary Bridges in Clinical Practice
- Neuropsychiatric Aspects of Sotos Syndrome: Explorative Review Building Multidisciplinary Bridges in Clinical Practice
- Prophylactic efficacy of an intranasal spray with 2 synergetic antibodies neutralizing Omicron
- Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy
- Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry
- Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome
- The CHD family chromatin remodeling enzyme, Kismet, promotes both clathrin-mediated and activity-dependent bulk endocytosis
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- 1,2-Dichloroethane causes anxiety and cognitive dysfunction in mice by disturbing GABA metabolism and inhibiting the cAMP-PKA-CREB signaling pathway
- CaMKII activity and metabolic imbalance-related neurological diseases: Focus on vascular dysfunction, synaptic plasticity, amyloid beta accumulation, and lipid metabolism
- New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
- Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5R59X knock-in mice
- Single-sequence protein structure prediction by integrating protein language models
- Advances in understanding migraine pathophysiology: a bench to bedside review of research insights and therapeutics
- Analyzing the Quality of Life in Individuals with Fragile X Syndrome in Relation to Sleep and Mental Health
- Exploring the epigenetic landscape: The role of 5-hydroxymethylcytosine in neurodevelopmental disorders
- Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models
- Insights into amyloid precursor protein target through PPI network analysis
- Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia
- The autism susceptibility kinase, TAOK2, phosphorylates eEF2 and modulates translation
- Loss-of-function of activity-dependent neuroprotective protein (ADNP) by a splice-acceptor site mutation causes Helsmoortel-Van der Aa syndrome
- Developing a pathway to clinical trials for CACNA1A-related epilepsies: A patient organization perspective
- Quantitative assessment of preanalytic variables on clinical evaluation of PI3/AKT/mTOR signaling activity in diffuse glioma
- Protein Research Seminar
- MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons
- NUS1 Variants Cause Lennox-Gastaut Syndrome Related to Unfolded Protein Reaction Activation
- Research progress of acupuncture regulating ERK signaling pathway in the treatment of depression
- Research progress of acupuncture regulating ERK signaling pathway in the treatment of depression
- Peripheral Blood Gene Expression Profiling Reveals Molecular Pathways Associated with Cervical Artery Dissection
- Tmod2 is a regulator of cocaine responses through control of striatal and cortical excitability, and drug-induced plasticity
- Identification of arginine-vasopressin receptor 1a (Avpr1a/AVPR1A) as a novel candidate gene for chronic visceral pain sheds light on the potential role of enteric neurons in the development of visceral hypersensitivity
- Lymphoblast transcriptome analysis in 22q11.2 deletion syndrome individuals with schizophrenia-spectrum disorder
- PFKFB3 controls acinar IP3R-mediated Ca2+ overload to regulate acute pancreatitis severity
- IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis
- The seeds of its regulation: natural antisense transcripts as single-gene control switches in neurodegenerative disorders
- Orexins and primary headaches: an overview of the neurobiology and clinical impact
- Presynaptic structural and functional plasticity are coupled by convergent Rap1 signaling
- Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a Drosophila knock-in tauopathy model
- Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease
Evidence Blueprint
Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Challenges in developing therapies in fragile X syndrome: how the FXLEARN trial can guide research
🌐 365 Days
VR Related Evidence Matrix
- The potential role of ribonucleic acid methylation in the pathological mechanisms of fragile X syndrome
- On-Tissue Spatial Proteomics Integrating MALDI-MS Imaging with Shotgun Proteomics Reveals Soy Consumption-Induced Protein Changes in a Fragile X Syndrome Mouse Model
- Role of Fragile X Messenger Ribonucleoprotein 1 in the pathophysiology of brain disorders: a glia perspective
- mGluR7 allosteric modulator AMN082 corrects protein synthesis and pathological phenotypes in FXS
- CNS-dominant human FMRP isoform rescues seizures, fear, and sleep abnormalities in Fmr1-KO mice
- Neurodevelopment and early pharmacological interventions in Fragile X Syndrome
- Loss of FMRP affects ovarian development and behaviour through multiple pathways in a zebrafish model of fragile X syndrome
- Effects of AFQ056 on language learning in fragile X syndrome
- Characterization of ribosome stalling and no-go mRNA decay stimulated by the Fragile X protein, FMRP
- Implication of the endocannabidiome and metabolic pathways in fragile X syndrome pathophysiology
- Phenotypic variability to medication management: an update on fragile X syndrome
- Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients
- Dysregulated COMT Expression in Fragile X Syndrome
- Peripheral Fragile X messenger ribonucleoprotein is required for the timely closure of a critical period for neuronal susceptibility in the ventral cochlear nucleus
- Investigating cell-specific effects of FMRP deficiency on spiny projection neurons in a mouse model of Fragile X syndrome
- Pharmacological management of fragile X syndrome: a systematic review and narrative summary of the current evidence
- Bisphenol F affects neurodevelopmental gene expression, mushroom body development and behavior in Drosophila melanogaster
- Novel Presynaptic Assay System Revealed That Metformin Ameliorates Exaggerated Synaptic Release and Munc18-1 Accumulation in Presynapses of Neurons from Fragile X Mouse Model
- Fragile X Syndrome and Fetal Alcohol Syndrome: Occurrence of Dual Diagnosis in a Set of Triplets
- Cerebellar contribution to autism-relevant behaviors in fragile X syndrome models
- Rescue of sharp wave-ripples and prevention of network hyperexcitability in the ventral but not the dorsal hippocampus of a rat model of fragile X syndrome
- Progranulin is an FMRP target that influences macroorchidism but not behaviour in a mouse model of Fragile X Syndrome
- Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons
- A novel combination treatment for fragile X syndrome predicted using computational methods
- PGC-1α integrates insulin signaling with mitochondrial physiology and behavior in a Drosophila model of Fragile X Syndrome
- Excitatory neuron-specific suppression of the integrated stress response contributes to autism-related phenotypes in fragile X syndrome
- Fragile X Syndrome in children
- A holistic approach to fragile X syndrome integrated guidance for person-centred care
- Similar Gap-Overlap Profiles in Children with Fragile X Syndrome and IQ-Matched Autism
- Topography and ensemble activity in auditory cortex of a mouse model of Fragile-X-Syndrome
- Assessment of dental and periodontal indices and Streptococcus mutans virulence in fragile X syndrome patients
- The atypical 'hippocampal' glutamate receptor coupled to phospholipase D that controls stretch-sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2
- Increased body weight in mice with fragile X messenger ribonucleoprotein 1 (Fmr1) gene mutation is associated with hypothalamic dysfunction
- Enrichment of the local synaptic translatome for genetic risk associated with schizophrenia and autism spectrum disorder
- Hippocampal Upregulation of Complement Component C3 in Response to Lipopolysaccharide Stimuli in a Model of Fragile-X Syndrome
- Neural correlates of face processing among preschoolers with fragile X syndrome, autism spectrum disorder, autism siblings, and typical development
- FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis
- Developmental Impairments of Synaptic Refinement in the Thalamus of a Mouse Model of Fragile X Syndrome
- Language Skills Influence Transition Planning in Adolescents With Fragile X Syndrome
- Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome
- Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need
- Assessment of the excitation-inhibition ratio in the Fmr1 KO2 mouse using neuronal oscillation dynamics
- Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: obligatory role of hippocampal GPR55 receptors
- Bridging the translational gap: what can synaptopathies tell us about autism?
- Increased degradation of FMRP contributes to neuronal hyperexcitability in tuberous sclerosis complex
- Prolonged and specific spatial training during adolescence reverses adult hippocampal network impairments in a mouse model of fragile X syndrome
- ADNP dysregulates methylation and mitochondrial gene expression in the cerebellum of a Helsmoortel-Van der Aa syndrome autopsy case
- Unravelling the link between neurodevelopmental disorders and short tandem CGG-repeat expansions
- SynGAP regulates synaptic plasticity and cognition independently of its catalytic activity
- Abnormal Brain Oscillations in Developmental Disorders: Application of Resting State EEG and MEG in Autism Spectrum Disorder and Fragile X Syndrome
- Hypnotic treatment reverses NREM sleep disruption and EEG desynchronization in a mouse model of Fragile X syndrome to rescue memory consolidation deficits
- New cases of recently described Thauvin-Robinet-Faivre syndrome with a novel homozygous FIBP gene variant
- Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
- Serotonin Signaling through Lipid Membranes
- Autism- and epilepsy-associated EEF1A2 mutations lead to translational dysfunction and altered actin bundling
- Glial dysregulation in the human brain in fragile X-associated tremor/ataxia syndrome
- Transient peripheral blood transcriptomic response to ketamine treatment in children with ADNP syndrome
- SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD
- Molecular profiling of the hippocampus of children with autism spectrum disorder
- Systemic pharmacological suppression of neural activity reverses learning impairment in a mouse model of Fragile X syndrome
- Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders
- Autistic Traits Associated with the Fragile X Premutation Allele: The Neurodevelopmental Profile
- Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research
- Cyfip2 controls the acoustic startle threshold through FMRP, actin polymerization, and GABA B receptor function